Principles of bioactive lipid signalling: lessons from sphingolipids

It has become increasingly difficult to find an area of cell biology in which lipids do not have important, if not key, roles as signalling and regulatory molecules. The rapidly expanding field of bioactive lipids is exemplified by many sphingolipids, such as ceramide, sphingosine, sphingosine-1-phosphate (S1P), ceramide-1-phosphate and lyso-sphingomyelin, which have roles in the regulation of cell growth, death, senescence, adhesion, migration, inflammation, angiogenesis and intracellular trafficking. Deciphering the mechanisms of these varied cell functions necessitates an understanding of the complex pathways of sphingolipid metabolism and the mechanisms that regulate lipid generation and lipid action.

[1]  J. Saba,et al.  Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren. , 2007, Trends in molecular medicine.

[2]  Y. Hannun,et al.  Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[4]  J. Thaikoottathil,et al.  Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells , 2007, Experimental cell research.

[5]  J. Gamble,et al.  Sphingosine Kinase Interacts with TRAF2 and Dissects Tumor Necrosis Factor-α Signaling* , 2002, The Journal of Biological Chemistry.

[6]  Korey R. Johnson,et al.  The sphingosine kinase 1/sphingosine‐1‐phosphate pathway mediates COX‐2 induction and PGE2 production in response to TNF‐α , 2003 .

[7]  Y. Igarashi,et al.  Calmodulin Is Involved in the Ca2+-dependent Activation of Ceramide Kinase as a Calcium Sensor* , 2005, Journal of Biological Chemistry.

[8]  Satoshi Yasuda,et al.  Molecular machinery for non-vesicular trafficking of ceramide , 2003, Nature.

[9]  M. Birnbaum,et al.  Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. , 2007, Cell metabolism.

[10]  Y. Hannun,et al.  Selective Inhibition of Juxtanuclear Translocation of Protein Kinase C βII by a Negative Feedback Mechanism Involving Ceramide Formed from the Salvage Pathway* , 2005, Journal of Biological Chemistry.

[11]  T. Linke,et al.  Characterization of sphingomyelinase activity released by thrombin-stimulated platelets , 2000, Molecular and Cellular Biochemistry.

[12]  Y. Hannun,et al.  Biochemical Properties of Mammalian Neutral Sphingomyelinase2 and Its Role in Sphingolipid Metabolism* , 2003, The Journal of Biological Chemistry.

[13]  Dieter Huesken,et al.  Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. , 2005, Cellular signalling.

[14]  J. P. Hobson,et al.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.

[15]  A. Merrill,et al.  Kinetics of long-chain (sphingoid) base biosynthesis in intact LM cells: effects of varying the extracellular concentrations of serine and fatty acid precursors of this pathway. , 1988, Biochemistry.

[16]  E. Tran,et al.  Direct Binding to Ceramide Activates Protein Kinase Cζ before the Formation of a Pro-apoptotic Complex with PAR-4 in Differentiating Stem Cells*[boxs] , 2005, Journal of Biological Chemistry.

[17]  E. Wang,et al.  Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. , 2001, Biochemical Society transactions.

[18]  W. Stoffel,et al.  Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Hallas,et al.  Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation , 2004, Cell Death and Differentiation.

[20]  A. Bielawska,et al.  Substrate specificity of human ceramide kinase Published, JLR Papers in Press, September 18, 2005. DOI 10.1194/jlr.M500313-JLR200 , 2005, Journal of Lipid Research.

[21]  A. Bielawska,et al.  The structural requirements for ceramide activation of serine-threonine protein phosphatases Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.M300347-JLR200 , 2004, Journal of Lipid Research.

[22]  K. Claffey,et al.  Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate , 1999, Cell.

[23]  S. Ben-Dor,et al.  When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)? , 2006, Journal of Biological Chemistry.

[24]  A. Bielawska,et al.  Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. , 2006, Methods.

[25]  D. Green,et al.  Role of Acidic Sphingomyelinase in Fas/CD95-mediated Cell Death* , 2000, The Journal of Biological Chemistry.

[26]  A. Bielawska,et al.  Involvement of Dihydroceramide Desaturase in Cell Cycle Progression in Human Neuroblastoma Cells* , 2007, Journal of Biological Chemistry.

[27]  Y. Hannun,et al.  Effects of sphingosine and other sphingolipids on protein kinase C. , 2000, Methods in enzymology.

[28]  Z. Fuks,et al.  Caspase-dependent and -independent Activation of Acid Sphingomyelinase Signaling* , 2005, Journal of Biological Chemistry.

[29]  P. Veldhoven,et al.  Further characterization of rat dihydroceramide desaturase: Tissue distribution, subcellular localization, and substrate specificity , 2000, Lipids.

[30]  F. Okajima Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? , 2002, Biochimica et biophysica acta.

[31]  R. Evers,et al.  The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. , 1999, Journal of cell science.

[32]  Y. Hannun,et al.  Identification of a novel amidase motif in neutral ceramidase. , 2006, The Biochemical journal.

[33]  Y. Hannun,et al.  Role for Neutral Sphingomyelinase-2 in Tumor Necrosis Factor α-Stimulated Expression of Vascular Cell Adhesion Molecule-1 (VCAM) and Intercellular Adhesion Molecule-1 (ICAM) in Lung Epithelial Cells , 2007, Journal of Biological Chemistry.

[34]  Y. Hannun,et al.  Acid Ceramidase but Not Acid Sphingomyelinase Is Required for Tumor Necrosis Factor-α-induced PGE2 Production* , 2006, Journal of Biological Chemistry.

[35]  A. Bielawska,et al.  The CLN9 Protein, a Regulator of Dihydroceramide Synthase* , 2006, Journal of Biological Chemistry.

[36]  K. Scotto,et al.  Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals , 1995, Cell.

[37]  I. López-Montero,et al.  Rapid Transbilayer Movement of Ceramides in Phospholipid Vesicles and in Human Erythrocytes* , 2005, Journal of Biological Chemistry.

[38]  A. Merrill,et al.  Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. , 2005, Methods.

[39]  Y. Hannun,et al.  Selective Substrate Supply in the Regulation of Yeast de Novo Sphingolipid Synthesis* , 2007, Journal of Biological Chemistry.

[40]  A. Futerman,et al.  Glycosphingolipidoses: Beyond the enzymatic defect , 2004, Glycoconjugate Journal.

[41]  Honglin Zhou,et al.  Inhibition of Akt Kinase by Cell-permeable Ceramide and Its Implications for Ceramide-induced Apoptosis* , 1998, The Journal of Biological Chemistry.

[42]  Jacek Bielawski,et al.  Role for Mammalian Neutral Sphingomyelinase 2 in Confluence-induced Growth Arrest of MCF7 Cells* , 2004, Journal of Biological Chemistry.

[43]  N. Radin Designing Anticancer Drugs via the Achilles Heel: Ceramide, Allylic Ketones, and Mitochondria , 2003 .

[44]  M. Hall,et al.  Sphingoid base signaling via Pkh kinases is required for endocytosis in yeast , 2001, The EMBO journal.

[45]  B. Strooper,et al.  Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin , 2005, Nature Cell Biology.

[46]  Mitra Poulami,et al.  マスト細胞からのスフィンゴシン‐1‐りん酸の運び出しに果たすABCC1の役割 , 2006 .

[47]  A. Bielawska,et al.  Role of Ceramide in Cellular Senescence (*) , 1995, The Journal of Biological Chemistry.

[48]  Y. Igarashi,et al.  Ceramide Kinase Is a Mediator of Calcium-dependent Degranulation in Mast Cells* , 2004, Journal of Biological Chemistry.

[49]  C. Leslie,et al.  Ceramide 1-Phosphate Is a Direct Activator of Cytosolic Phospholipase A2* , 2004, Journal of Biological Chemistry.

[50]  Korey R. Johnson,et al.  PKC-dependent Activation of Sphingosine Kinase 1 and Translocation to the Plasma Membrane , 2002, The Journal of Biological Chemistry.

[51]  A. Karakashian,et al.  Expression of neutral sphingomyelinase‐2 (NSMase‐2) in primary rat hepatocytes modulates IL‐β‐induced JNK activation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  S. Spiegel,et al.  Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling , 2005, Journal of Cell Science.

[53]  Y. Hannun,et al.  Acid and neutral sphingomyelinases: roles and mechanisms of regulation. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[54]  Y. Nishizuka Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[55]  D. Brindley Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division, and cancer , 2004, Journal of cellular biochemistry.

[56]  A. Morris,et al.  Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. , 2005, The Biochemical journal.

[57]  R. Gonsette New immunosuppressants with potential implication in multiple sclerosis , 2004, Journal of the Neurological Sciences.

[58]  S. Payne,et al.  Role of ABCC1 in export of sphingosine-1-phosphate from mast cells , 2006, Proceedings of the National Academy of Sciences.

[59]  J. Gamble,et al.  Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[61]  R. Lester,et al.  Functions and metabolism of sphingolipids in Saccharomyces cerevisiae. , 2006, Progress in lipid research.

[62]  Y. Hannun,et al.  The extended family of neutral sphingomyelinases. , 2006, Biochemistry.

[63]  Y. Hannun,et al.  De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells , 2002, The Journal of Biological Chemistry.

[64]  M. Cabot,et al.  Glycosphingolipids and drug resistance. , 2006, Biochimica et biophysica acta.

[65]  S. Pyne,et al.  Sphingosine Kinase 1 Is an Intracellular Effector of Phosphatidic Acid* , 2004, Journal of Biological Chemistry.

[66]  J. Xu,et al.  Amyloid‐β peptide enhances tumor necrosis factor‐α‐induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes , 2005 .

[67]  S. Milstien,et al.  Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. , 2006, Biochimica et biophysica acta.

[68]  R. Kolesnick,et al.  Kinase Suppressor of Ras Is Ceramide-Activated Protein Kinase , 1997, Cell.

[69]  E. Clementi,et al.  Endothelial Nitric Oxide Synthase Activation by Tumor Necrosis Factor α Through Neutral Sphingomyelinase 2, Sphingosine Kinase 1, and Sphingosine 1 Phosphate Receptors: A Novel Pathway Relevant to the Pathophysiology of Endothelium , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[70]  L. Sandirasegarane,et al.  Ceramide-induced Inhibition of Akt Is Mediated through Protein Kinase Cζ , 2002, The Journal of Biological Chemistry.

[71]  S. Menéndez,et al.  Cell Autonomous Apoptosis Defects in Acid Sphingomyelinase Knockout Fibroblasts* , 2001, The Journal of Biological Chemistry.

[72]  J. Heitman,et al.  Phytosphingosine as a Specific Inhibitor of Growth and Nutrient Import in Saccharomyces cerevisiae * , 2001, The Journal of Biological Chemistry.

[73]  Y. Hannun,et al.  Loss of sphingosine kinase‐1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  H. Riezman,et al.  Sphingoid base is required for translation initiation during heat stress in Saccharomyces cerevisiae. , 2005, Molecular biology of the cell.

[75]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[76]  Y. Hannun,et al.  BcR-induced Apoptosis Involves Differential Regulation of C16 and C24-Ceramide Formation and Sphingolipid-dependent Activation of the Proteasome* , 2003, The Journal of Biological Chemistry.

[77]  F. Tafesse,et al.  The Multigenic Sphingomyelin Synthase Family* , 2006, Journal of Biological Chemistry.

[78]  C. H. Liu,et al.  Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.

[79]  C. Bishop,et al.  A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse , 2005, Nature Genetics.

[80]  Eberhard O. Voit,et al.  Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae , 2005, Nature.

[81]  Y. Hannun,et al.  Analysis of membrane topology of neutral sphingomyelinase 2 , 2007, FEBS letters.

[82]  S. Spiegel,et al.  Ceramide 1-Phosphate, a Mediator of Phagocytosis* , 2005, Journal of Biological Chemistry.

[83]  B. Wattenberg,et al.  The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function Published, JLR Papers in Press, March 6, 2006. , 2006, Journal of Lipid Research.

[84]  T. Hla Physiological and pathological actions of sphingosine 1-phosphate. , 2004, Seminars in cell & developmental biology.

[85]  A. Dobierzewska,et al.  Aging in rat causes hepatic hyperresposiveness to interleukin‐1β which is mediated by neutral sphingomyelinase‐2 , 2007, Hepatology.

[86]  Y. Hannun,et al.  Translational aspects of sphingolipid metabolism. , 2007, Trends in molecular medicine.

[87]  Y. Hannun,et al.  Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide , 2007, Nature.

[88]  W. Stoffel,et al.  Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression. , 2007, The American journal of pathology.

[89]  M. Fujita,et al.  cca1 Is Required for Formation of Growth-arrested Confluent Monolayer of Rat 3Y1 Cells* , 1997, The Journal of Biological Chemistry.

[90]  R. Unger Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0870 Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome , 2022 .

[91]  E. Gulbins,et al.  Rhinoviruses Infect Human Epithelial Cells via Ceramide-enriched Membrane Platforms* , 2005, Journal of Biological Chemistry.

[92]  S. Hakomori Traveling for the glycosphingolipid path , 2000, Glycoconjugate Journal.

[93]  Y. Hannun,et al.  Serine Palmitoyltransferase Regulates de NovoCeramide Generation during Etoposide-induced Apoptosis* , 2000, The Journal of Biological Chemistry.

[94]  M. Vadas,et al.  Activation of sphingosine kinase 1 by ERK1/2‐mediated phosphorylation , 2003, The EMBO journal.

[95]  Janet M. Allen,et al.  FcγRI Coupling to Phospholipase D Initiates Sphingosine Kinase-mediated Calcium Mobilization and Vesicular Trafficking* , 1998, The Journal of Biological Chemistry.

[96]  R. Proia,et al.  Essential Role for Sphingosine Kinases in Neural and Vascular Development , 2005, Molecular and Cellular Biology.

[97]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[98]  H. Schaller,et al.  Role of the G-Protein-Coupled Receptor GPR12 as High-Affinity Receptor for Sphingosylphosphorylcholine and Its Expression and Function in Brain Development , 2003, The Journal of Neuroscience.

[99]  Y. Hannun,et al.  Ceramide Inactivates Cellular Protein Kinase Cα* , 1996, The Journal of Biological Chemistry.

[100]  L. Hokin,et al.  Enzyme secretion and the incorporation of P32 into phospholipides of pancreas slices. , 1953, The Journal of biological chemistry.

[101]  S. Peters,et al.  Sphingosine-1-phosphate signaling in the cardiovascular system. , 2007, Current opinion in pharmacology.

[102]  D. Fabbro,et al.  PKC zeta is a molecular switch in signal transduction of TNF‐alpha, bifunctionally regulated by ceramide and arachidonic acid. , 1995, The EMBO journal.

[103]  Y. Hannun,et al.  Activation of Acid Sphingomyelinase by Protein Kinase Cδ-mediated Phosphorylation* , 2007, Journal of Biological Chemistry.

[104]  W. Stoffel,et al.  Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation , 2000, Cell Death and Differentiation.

[105]  H. Rosen,et al.  Egress: a receptor‐regulated step in lymphocyte trafficking , 2003, Immunological reviews.

[106]  Korey R. Johnson,et al.  Role of Human Sphingosine-1-phosphate Phosphatase 1 in the Regulation of Intra- and Extracellular Sphingosine-1-phosphate Levels and Cell Viability* , 2003, Journal of Biological Chemistry.

[107]  Yusuf A. Hannun,et al.  The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind* , 2002, The Journal of Biological Chemistry.

[108]  Y. Hirabayashi,et al.  Glucosylceramide synthase and glycosphingolipid synthesis. , 1998, Trends in cell biology.

[109]  N. Radin,et al.  Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. , 1993, Advances in lipid research.

[110]  Wei Hu,et al.  Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  Y. Hannun,et al.  A novel role for protein kinase Cδ‐mediated phosphorylation of acid sphingomyelinase in UV light‐induced mitochondrial injury , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[112]  Y. Hannun,et al.  Cystic Fibrosis Transmembrane Regulator Regulates Uptake of Sphingoid Base Phosphates and Lysophosphatidic Acid , 2001, The Journal of Biological Chemistry.

[113]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[114]  T. Hla,et al.  Lysophospholipids--Receptor Revelations , 2001, Science.

[115]  M. Cabot,et al.  Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. , 2006, Biochimica et biophysica acta.

[116]  L. Obeid,et al.  Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. , 2004, Biochimica et biophysica acta.

[117]  K. Pfizenmaier,et al.  Regulation of secretory transport by protein kinase D–mediated phosphorylation of the ceramide transfer protein , 2007, The Journal of cell biology.

[118]  A. Gomez-Muñoz Ceramide 1-phosphate/ceramide, a switch between life and death. , 2006, Biochimica et biophysica acta.

[119]  Y. Hannun,et al.  Use of D-erythro-sphingosine as a pharmacological inhibitor of protein kinase C in human platelets. , 1990, The Biochemical journal.